Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 17-AAG | 0.001 | uM | 9 | 5000.00 | 3570.27 | 5875.00 | 5872.75 | 1.0004 | 1.0011 |
| SK-BR-3 | Lapatinib | 10 | uM | 9 | 5000.00 | 3570.27 | 2995.00 | 5872.75 | 0.5100 | -0.2171 |
| SK-BR-3 | 0 | uM | 9 | 5000.00 | 3570.27 | 5686.00 | 5872.75 | 0.9682 | 0.9120 | |
| SK-BR-3 | 0 | uM | 9 | 5000.00 | 3570.27 | 5892.00 | 5872.75 | 1.0033 | 1.0091 | |
| SK-BR-3 | 17-AAG | 0.000066069 | uM | 9 | 5000.00 | 3570.27 | 5929.00 | 5872.75 | 1.0096 | 1.0267 |
| SK-BR-3 | 0 | uM | 9 | 5000.00 | 3570.27 | 5739.00 | 5872.75 | 0.9772 | 0.9369 | |
| SK-BR-3 | 0 | uM | 9 | 5000.00 | 3570.27 | 5947.00 | 5872.75 | 1.0126 | 1.0353 | |
| SK-BR-3 | Erlotinib | 0.01 | uM | 9 | 5000.00 | 3570.27 | 5713.00 | 5872.75 | 0.9728 | 0.9246 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 9 | 5000.00 | 3570.27 | 5374.00 | 5872.75 | 0.9151 | 0.7675 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 9 | 5000.00 | 3570.27 | 3267.00 | 5872.75 | 0.5563 | -0.1163 |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 9 | 5000.00 | 3570.27 | 4569.00 | 5872.75 | 0.7780 | 0.4099 |
| SK-BR-3 | Linsitinib | 0.01 | uM | 9 | 5000.00 | 3570.27 | 5754.00 | 5872.75 | 0.9798 | 0.9439 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 9 | 5000.00 | 3570.27 | 5738.00 | 5872.75 | 0.9771 | 0.9364 |
| SK-BR-3 | Lapatinib | 0.01 | uM | 9 | 5000.00 | 3570.27 | 5209.00 | 5872.75 | 0.8870 | 0.6923 |
| SK-BR-3 | 17-AAG | 0.031623 | uM | 9 | 5000.00 | 3570.27 | 4127.00 | 5872.75 | 0.7027 | 0.2236 |
| SK-BR-3 | Lapatinib | 0.1 | uM | 9 | 5000.00 | 3570.27 | 3988.00 | 5872.75 | 0.6791 | 0.1666 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 9 | 5000.00 | 3570.27 | 5958.00 | 5872.75 | 1.0145 | 1.0405 |
| SK-BR-3 | Linsitinib | 0.31623 | uM | 9 | 5000.00 | 3570.27 | 5840.00 | 5872.75 | 0.9944 | 0.9845 |
| SK-BR-3 | Lapatinib | 0.0016596 | uM | 9 | 5000.00 | 3570.27 | 5891.00 | 5872.75 | 1.0031 | 1.0087 |
| SK-BR-3 | 17-AAG | 0.01 | uM | 9 | 5000.00 | 3570.27 | 5238.00 | 5872.75 | 0.8919 | 0.7055 |
| SK-BR-3 | Lapatinib | 0.031623 | uM | 9 | 5000.00 | 3570.27 | 4341.00 | 5872.75 | 0.7392 | 0.3129 |
| SK-BR-3 | Lapatinib | 0.0033113 | uM | 9 | 5000.00 | 3570.27 | 5632.00 | 5872.75 | 0.9590 | 0.8867 |
| SK-BR-3 | 17-AAG | 0.1 | uM | 9 | 5000.00 | 3570.27 | 3470.00 | 5872.75 | 0.5909 | -0.0389 |
| SK-BR-3 | Linsitinib | 0.0033113 | uM | 9 | 5000.00 | 3570.27 | 6046.00 | 5872.75 | 1.0295 | 1.0826 |
| SK-BR-3 | Linsitinib | 3.1623 | uM | 9 | 5000.00 | 3570.27 | 5201.00 | 5872.75 | 0.8856 | 0.6887 |